These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 17266262

  • 21. The role of conformation in ion permeation in a K+ channel.
    Domene C, Vemparala S, Furini S, Sharp K, Klein ML.
    J Am Chem Soc; 2008 Mar 19; 130(11):3389-98. PubMed ID: 18293969
    [Abstract] [Full Text] [Related]

  • 22. The pore domain outer helix contributes to both activation and inactivation of the HERG K+ channel.
    Ju P, Pages G, Riek RP, Chen PC, Torres AM, Bansal PS, Kuyucak S, Kuchel PW, Vandenberg JI.
    J Biol Chem; 2009 Jan 09; 284(2):1000-8. PubMed ID: 18996846
    [Abstract] [Full Text] [Related]

  • 23. Molecular determinants of gating at the potassium-channel selectivity filter.
    Cordero-Morales JF, Cuello LG, Zhao Y, Jogini V, Cortes DM, Roux B, Perozo E.
    Nat Struct Mol Biol; 2006 Apr 09; 13(4):311-8. PubMed ID: 16532009
    [Abstract] [Full Text] [Related]

  • 24. Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.
    Duncan RS, Ridley JM, Dempsey CE, Leishman DJ, Leaney JL, Hancox JC, Witchel HJ.
    Biochem Biophys Res Commun; 2006 Mar 10; 341(2):500-6. PubMed ID: 16446155
    [Abstract] [Full Text] [Related]

  • 25. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
    Duan JJ, Ma JH, Zhang PH, Wang XP, Zou AR, Tu DN.
    Acta Pharmacol Sin; 2007 Jul 10; 28(7):959-67. PubMed ID: 17588331
    [Abstract] [Full Text] [Related]

  • 26. Refining insights into high-affinity drug binding to the human ether-à-go-go-related gene potassium channel.
    Hancox JC, James AF.
    Mol Pharmacol; 2008 Jun 10; 73(6):1592-5. PubMed ID: 18381562
    [Abstract] [Full Text] [Related]

  • 27. NMR solution structure of the N-terminal domain of hERG and its interaction with the S4-S5 linker.
    Li Q, Gayen S, Chen AS, Huang Q, Raida M, Kang C.
    Biochem Biophys Res Commun; 2010 Dec 03; 403(1):126-32. PubMed ID: 21055387
    [Abstract] [Full Text] [Related]

  • 28. APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human ether-a-go-go- related potassium channel.
    Zhang M, Liu XS, Diochot S, Lazdunski M, Tseng GN.
    Mol Pharmacol; 2007 Aug 03; 72(2):259-68. PubMed ID: 17473056
    [Abstract] [Full Text] [Related]

  • 29. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels.
    Lipkind GM, Fozzard HA.
    Mol Pharmacol; 2005 Dec 03; 68(6):1611-22. PubMed ID: 16174788
    [Abstract] [Full Text] [Related]

  • 30. The hERG potassium channel and drug trapping: insight from docking studies with propafenone derivatives.
    Thai KM, Windisch A, Stork D, Weinzinger A, Schiesaro A, Guy RH, Timin EN, Hering S, Ecker GF.
    ChemMedChem; 2010 Mar 01; 5(3):436-42. PubMed ID: 20146282
    [Abstract] [Full Text] [Related]

  • 31. The S4-S5 linker acts as a signal integrator for HERG K+ channel activation and deactivation gating.
    Ng CA, Perry MD, Tan PS, Hill AP, Kuchel PW, Vandenberg JI.
    PLoS One; 2012 Mar 01; 7(2):e31640. PubMed ID: 22359612
    [Abstract] [Full Text] [Related]

  • 32. Early Steps in C-Type Inactivation of the hERG Potassium Channel.
    Pettini F, Domene C, Furini S.
    J Chem Inf Model; 2023 Jan 09; 63(1):251-258. PubMed ID: 36512342
    [Abstract] [Full Text] [Related]

  • 33. A gate in the selectivity filter of potassium channels.
    Bernèche S, Roux B.
    Structure; 2005 Apr 09; 13(4):591-600. PubMed ID: 15837197
    [Abstract] [Full Text] [Related]

  • 34. Topological mapping of the asymmetric drug binding to the human ether-à-go-go-related gene product (HERG) potassium channel by use of tandem dimers.
    Myokai T, Ryu S, Shimizu H, Oiki S.
    Mol Pharmacol; 2008 Jun 09; 73(6):1643-51. PubMed ID: 18326583
    [Abstract] [Full Text] [Related]

  • 35. Conformational dynamics of the inner pore helix of voltage-gated potassium channels.
    Choe S, Grabe M.
    J Chem Phys; 2009 Jun 07; 130(21):215103. PubMed ID: 19508102
    [Abstract] [Full Text] [Related]

  • 36. A composite model for HERG blockade.
    Kramer C, Beck B, Kriegl JM, Clark T.
    ChemMedChem; 2008 Feb 07; 3(2):254-65. PubMed ID: 18061919
    [Abstract] [Full Text] [Related]

  • 37. Ion-blocking sites of the Kir2.1 channel revealed by multiscale modeling.
    Tai K, Stansfeld PJ, Sansom MS.
    Biochemistry; 2009 Sep 15; 48(36):8758-63. PubMed ID: 19653656
    [Abstract] [Full Text] [Related]

  • 38. Free energy of a potassium ion in a model of the channel formed by an amphipathic leucine-serine peptide.
    Smith GR, Sansom MS.
    Eur Biophys J; 2002 Jun 15; 31(3):198-206. PubMed ID: 12029332
    [Abstract] [Full Text] [Related]

  • 39. Assessing hERG pore models as templates for drug docking using published experimental constraints: the inactivated state in the context of drug block.
    Dempsey CE, Wright D, Colenso CK, Sessions RB, Hancox JC.
    J Chem Inf Model; 2014 Feb 24; 54(2):601-12. PubMed ID: 24471705
    [Abstract] [Full Text] [Related]

  • 40. Novel alpha-KTx sites in the BK channel and comparative sequence analysis reveal distinguishing features of the BK and KV channel outer pore.
    Giangiacomo KM, Becker J, Garsky C, Schmalhofer W, Garcia ML, Mullmann TJ.
    Cell Biochem Biophys; 2008 Feb 24; 52(1):47-58. PubMed ID: 18815746
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.